Chronic Refractory Cough Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Antibiotics, Decongestants, Corticosteroids, Antihistamines, Acid Blockers, Others), By Route of Administration (Oral, Nasal, Parenteral, and Others) By End User (Hospitals, Clinics, Homecare, Others) and Region

Chronic Refractory Cough Market Regional Analysis

The chronic Refractory Cough market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. As per the World Health Organization, approximately 235 million people were living with asthma, in 2017. According to the Centers for Disease Control and Prevention data 2019, 1 in every 3 people has asthma, accounting for about 25 million people in the USA. In the Asia Pacific, Middle East, and Africa, chronic disease conditions are on the rise due to rising pollution and infections, i.e., over 60 to 70% of patients in the countries are diagnosed with respiratory diseases, and nearly 30% people are addicted to smoking in these regions. The North America Chronic Refractory Cough market is expected to dominate the market over the forecast period, majorly because of the highly developed healthcare systems in the United States and Canada, as well as the strong presence of major market players, and the rising prevalence and incidence of chronic diseases in the region. Moreover, in the Asia Pacific region, the rise in the patient population and the expansion of products to treat chronic cough with increasing government initiatives to reduce chronic diseases are the major growth factors for the market.